picropodophyllin has been researched along with Esophageal Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chae, JI; Cho, SS; Kwak, AW; Lee, MH; Shim, JH; Yoon, G | 1 |
Dyrager, C; Fryknäs, M; Gullbo, J; Lennartsson, J; Sooman, L; Wickström, M; Wu, X | 1 |
2 other study(ies) available for picropodophyllin and Esophageal Neoplasms
Article | Year |
---|---|
Picropodophyllotoxin, an Epimer of Podophyllotoxin, Causes Apoptosis of Human Esophageal Squamous Cell Carcinoma Cells Through ROS-Mediated JNK/P38 MAPK Pathways.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Proliferation; Endoplasmic Reticulum Stress; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Isomerism; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mitochondria; Mitogen-Activated Protein Kinase 8; p38 Mitogen-Activated Protein Kinases; Podophyllotoxin; Reactive Oxygen Species; Signal Transduction | 2020 |
Alternative cytotoxic effects of the postulated IGF-IR inhibitor picropodophyllin in vitro.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Dose-Response Relationship, Drug; ErbB Receptors; Esophageal Neoplasms; Humans; Microtubules; Phosphorylation; Podophyllotoxin; Protein Kinase Inhibitors; Receptor, IGF Type 1; Signal Transduction; Tubulin Modulators | 2013 |